Broadfin Capital’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-2,034,103
| Closed | -$2.75M | – | 57 |
|
|
2017
Q2 | $2.75M | Sell |
2,034,103
-3,157,487
| -61% | -$4.26M | 0.33% | 37 |
|
|
2017
Q1 | $11.1M | Buy |
5,191,590
+400,000
| +8% | +$856K | 1.35% | 22 |
|
|
2016
Q4 | $21.1M | Buy |
4,791,590
+384,600
| +9% | +$1.7M | 2.35% | 13 |
|
|
2016
Q3 | $21.4M | Buy |
4,406,990
+300,000
| +7% | +$1.46M | 1.92% | 14 |
|
|
2016
Q2 | $13.6M | Buy |
4,106,990
+306,990
| +8% | +$1.01M | 1.32% | 20 |
|
|
2016
Q1 | $13.5M | Buy |
+3,800,000
| New | +$13.5M | 1.3% | 18 |
|